CATEGORIES
- HGH & Peptide
- Testosterone Series
- Nandrolone Series
- Boldenon Series
- Trenbolone Series
- DHEA Series
- Oral Steroids Series
- Antiestrogen Series
- Estrogen series
- Epinephrine & Thyroxine
- Nootropic API
- SARMs
- Finished Steroid
- Molecularly targeted cancer API
Latest news
- The dosage of HGH
- The History of HGH
- What is HGH?
- High Growth hormone
- How to use HGH?
- The Copy of Growth Hormone
Contact us
- ADD: HongKong
- TEL: skype: sophia.koffeepharm
- FAX: sophia@koffeepharm.com
- E-mail: sophia@koffeepharm.com
Lanreotide
- Product description: supply good quality Lanreotide CAS: 108736-35-2
PRODUCT INTRODUCTION
|
Lanreotide |
|||
Product Name: |
Lanreotide |
Usage: |
Peptide Powder |
|
MOQ: |
1 Kit |
Payment Terms: |
Western Union, MoneyGram, T/T, Bitcoin |
|
Courier: |
EMS, HKEMS, FedEx, TNT, DHL |
Supply Ability: |
100 Kg Per Month |
|
Appearance: |
White Or Almost White Crystalline Powder |
Suitable For: |
Adult |
|
Assay: |
97.0~103.0% |
Fuction: |
Steroid Raw Material For Bodyduilding |
|
Sample: |
Available |
Shipping Port: |
HONGKONG |
Basic Info
Port: Hong Kong, Hong Kong
Production Capacity:1500kg/Month
Payment Terms:T/T, Western Union, Money Gram, Bitcoin
Model NO.: 108736-35-2
Customized: Non-Customized
Suitable for: Elderly, Adult
Purity: >99%
Market: Worldwide
Trademark: HKYC
Specification: 100ml 200ml 500ml
HS Code: 3002200000
Powder: Yes
Certification: ISO 9001
State: Solid
Sample: Free
Usage: Increasing Lean Mass Gains & Weight Loss
Transport Package: 1kg/Plastic Bottle or as Required
Origin: Made-in-China
99% Lanreotide Peptides Muscle Fitness with Best Quality
Product Description
Important Notification: All of our products and services listed in this website are for research or production use only, not for direct human use.
Raw powder Lanreotide 108736-35-2
Synonyms: LANREOTIDE;AUTOGEL;BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE;BIM-23014;ANGIOPEPTIN;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, (DISULFIDE BOND);IPSTYL
MF: C54H69N11O10S2
MW: 1096.32
CAS:108736-35-2
Assay:98%
Appearance:white to off-white lyophilised powder
Packing:plastic vial (dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement.
Storage:a cool(2~8 degree C) & dry place protected from light, keep package close when not in use.
Lanreotide-------Pharmacology
Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. However, while somatostatin is quickly broken down in the body (within minutes), lanreotide has a much longer half-life, and produces far more prolonged effects.The efficacy of lanreotide has not been extensively studied, and results differ greatly between trials and formulations.
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.
Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.
Lanreotide-------Indications
Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes.
Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
Lanreotide ,In Dec 2014 the US FDA approved lanreotide for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Company advantages:
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia
Related: Muscle & Fitness, Biology, Essential Oils, MMA Pro Fighter , Bodyboarding, Muscle & Strength, Alcohol, Growth hormone, Gym, Public Health, Cannabis, Steroids, Washington, Dietary supplement, Exercising, Accountability, Herbs, Professional bodybuilding, Lifting weights.